Tempest Therapeutics downgraded by H.C. Wainwright
$TPST
Biotechnology: Pharmaceutical Preparations
Health Care
H.C. Wainwright downgraded Tempest Therapeutics from Buy to Neutral
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/10/2025 | Sector Outperform → Sector Perform | Scotiabank | |
| 4/10/2025 | Buy → Neutral | H.C. Wainwright | |
| 3/14/2024 | $13.00 | Sector Outperform | Scotiabank |
| 2/8/2024 | $15.00 | Buy | Jefferies |
| 10/21/2021 | Outperform | William Blair | |
| 7/13/2021 | $51.00 | Buy | HC Wainwright & Co. |
4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)